System Transmission

Top Signal

100#1 JOB

Activity

2178Ripe

+919 today

System

Live1m

Terminal Asset View

stockNASDAQ

BYSI

$1.69+3.68%

BeyondSpring Inc

Ripening

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

67Ripening

Live Analysis Active

Company Mission

BeyondSpring creates medicines that fight cancer by targeting specific proteins found in tumor cells. Doctors and hospitals use these experimental drugs in clinical trials to treat patients with certain types of cancer. The company makes money by conducting these trials and hopes to eventually sell approved drugs to healthcare providers.

BYS

Industry Context

Biotechnology companies develop medical treatments through scientific research. This industry experiences high volatility when clinical trial results are announced, as successful trials can lead to major price moves while failed trials can cause sharp declines.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

55Matrix

Market Momentum

65.4— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.4x— Normal Volume

Today's Change

3.68%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing BYSI across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:16 AM UTC

As-of 03-15-2026 04:00 UTC

Develops cancer drugs and sells them to hospitals and pharmacies after clinical trials prove they work.

Weekly price range has been narrowing for several weeks, suggesting the stock is coiling tighter before a potential significant move.

Biotech sector volatility often increases during clinical trial results, creating opportunities for stocks like this with compressed trading ranges.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...